Peptidyl-Lys Metalloendopeptidase-catalyzed 18O Labeling for Comparative Proteomics

Application to Cytokine/Lipolysaccharide-treated Human Retinal Pigment Epithelium Cell Line*,S

K. C. Sekhar Rao{ddagger}, Vikram Palamalai{ddagger}, Jane R. Dunlevy§ and Masaru Miyagi{ddagger},

From the Departments of {ddagger} Biochemistry and Molecular Biology and § Anatomy and Cell Biology, University of North Dakota School of Medicine and Health Sciences, Grand Forks, North Dakota 58203


    ABSTRACT
 TOP
 ABSTRACT
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
We recently proposed a comparative proteomic method utilizing proteolytic 18O labeling of peptides catalyzed by peptidyl-Lys metalloendopeptidase (Lys-N) (Rao, K. C. S., Carruth, R. T., and Miyagi, M. (2005) Proteolytic 18O labeling by peptidyl-Lys metalloendopeptidase for comparative proteomics. J. Proteome Res. 4, 507–514). Unlike trypsin, which generates a mixture of isotopic isoforms resulting from the incorporation of one or two 18O atoms into each peptide species, Lys-N incorporates only a single 18O atom into the carboxyl terminus of each proteolytically generated peptide in H218O solvent. This study reports the first biological application of the Lys-N-based proteolytic 18O labeling method, characterizing the proteome changes of cytokine/lipopolysaccharide-treated verses untreated human retinal pigment epithelium (ARPE-19) cells. The study resulted not only in the identification of 584 proteins but also the determination of the relative abundances of 562 proteins in the two proteomes. The results demonstrate the usefulness of the Lys-N-based proteolytic 18O labeling method in comparative proteomic studies. The results also provide the most comprehensive description of the retinal pigment epithelium proteome to date.


Large scale quantitative measurements of protein expressions in different sets of samples (comparative proteomics) are expected to be critical to the advance of our understanding of physiological processes and disease mechanisms. Although 2D1 PAGE-based methods have been the primary choice in comparative proteomics, 2D gels are cumbersome to run, have a poor dynamic range, and are biased toward abundant and soluble proteins (1). Therefore alternative methods have been actively sought. One such method is mass spectrometry-based in vitro stable isotope labeling in which proteins from the control and experimental samples are proteolytically digested. The generated peptides from the control sample are then labeled with naturally abundant (light) isotope(s), whereas the peptides from the experimental sample are labeled with its heavier isotope(s) or vice versa. The samples are then mixed together in equal proportions, and the relative abundance of each particular peptide from the two samples is determined by mass spectrometry. By comparing the peak areas or intensities of the light and heavy peptides, the relative abundance of each particular peptide can be determined; this equals the relative abundance in the original samples of the parent protein from which the peptide was generated.

Among the mass spectrometry-based in vitro stable isotope labeling methods, the proteolytic 18O labeling method (2) is particularly attractive because it has the least technical variations. In this method, the stable isotopic (18O atom) labeling of peptides is achieved concurrently with the proteolytic digestion of proteins. Therefore the yield of each isotopically labeled peptide depends only on the effectiveness of proteolytic digestion in both samples compared. In contrast, the other in vitro stable isotope labeling methods (such as the isotope-coded affinity tag method (3)) have the isotopic labeling and proteolytic digestion of proteins occurring at different steps, meaning that the yield of each isotopically labeled peptide has greater variability because it depends on both the yield of the isotope labeling and the effectiveness of the proteolytic digestion.

Trypsin has been the protease most utilized in proteolytic 18O labeling methods. However, it is known that trypsin generates a mixture of isotopic isoforms resulting from the variable incorporation of either one or two 18O atoms (18O1/18O2) into each peptide (4). This not only makes quantification of the peptides complicated but also increases the error in the experimentally determined 16O- and 18O-labeled peptides ratios. We recently reported a Lys-N-based technique, which is advantageous over tryptic digestion because it incorporates only a single 18O atom into the carboxyl terminus of each proteolytically generated peptide (5). Lys-N is a metalloendopeptidase (peptidyl-Lys metalloendopeptidase, EC 3.4.24.20) that cleaves specifically peptidyl-lysine bonds (-X-Lys-) in proteins and peptides (6). In this initial study with several model proteins the unique single 18O atom incorporation property of Lys-N was shown to provide accurate quantification results. Other advantages of the Lys-N-based technique shown in this initial study include no enzyme-catalyzed 18O back exchange and production of a less complex protein digest.

Here we report the first biological application of the Lys-N-based proteolytic 18O labeling method, demonstrating the technique on cytokine/lipopolysaccharide (LPS)-treated versus untreated (control) human retinal pigment epithelium (ARPE-19) cells. Retinal pigment epithelium (RPE) performs many functions required for the neural retina to work properly, including transport of nutrients and removal of waste products into/from the photoreceptor cells, regeneration of bleached visual pigment, and phagocytosis of the outer segments of the rods and cones. ARPE-19 was developed as a spontaneous derived cell line using cells from a 19-year-old male donor and is an in vitro model system of RPE that is ideal for physiological and biochemical studies (7). Effects of cytokine treatment, including tumor necrosis factor {alpha} and interferon-{gamma}, on cultured RPE and ARPE-19 cells have been studied extensively, and the induction of several proteins have been reported (811). In addition, several proteomic studies on RPE or RPE-derived cell lines have also been reported (1215). Therefore, ARPE-19 cells (±cytokine treatment) will serve as a good model system to evaluate the Lys-N-based proteolytic 18O labeling method.

The goal of this study was to evaluate the practicability of Lys-N-based proteolytic 18O labeling method with biological samples. The study resulted in identification of about 600 proteins along with semiquantitative information on their expressions in the cytokine/LPS-treated and untreated cells with a minimum detection accuracy of a 2-fold change. This method can thus be used as a general comparative proteomic technique applied to other systems. The results also provide a more complete description of the proteome in ARPE-19 cells and proteome changes resulting from cytokine/LPS treatment.


    EXPERIMENTAL PROCEDURES
 TOP
 ABSTRACT
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Materials
Lys-N from Grifola frondosa was obtained from Seikagaku Corp. (Tokyo, Japan). Oxygen-18-enriched water (>95%) and HPLC grade water were obtained from Spectra Stable Isotopes (Columbia, MD) and Fisher Scientific, respectively. All other chemicals used were of analytical grade or the highest quality that was commercially available.

Cell Culture, Cytokine/LPS Treatment, and Cell Harvest
Human retinal pigment epithelium (ARPE-19) cells were obtained from the American Tissue Culture Collection (Manassas, VA). Cells were cultured to ~80% confluency in T-175 flasks as described previously (16) at 37 °C under 95% air and 5% CO2 in Dulbecco’s modified Eagle’s medium:nutrient mixture F-12 (Ham’s) 1:1 (DMEM-F12) with 10% fetal calf serum, 2% L-glutamine, and 0.5% antibiotic/antimycotic. The cells, before harvesting, were either 1) treated in growth medium for 24 h with a combination of cytokines/LPS consisting of human tumor necrosis factor {alpha} (3.25 ng/ml, Upstate Biotechnology, Lake Placid, NY), human interferon-{gamma} (50 ng/ml, Upstate Biotechnology), and Escherichia coli LPS (10 µg/ml, Sigma-Aldrich, St. Louis, MO) or 2) untreated (control), keeping them in medium for 24 h. After 24 h, the medium was removed from the flask, and the cells were washed with PBS twice and DMEM-F12 once and harvested in DMEM-F12 by scraping the cells from the flask. The harvested cell suspension was centrifuged at 150 x g for 10 min at 4 °C, the supernatant was removed, and the cell pellet was stored at –80 °C until use.

Protein Extraction and S-Carbamidomethylation
The stored cell pellet was resuspended in 2.5 ml of 2% SDS in 50 mM Tris-HCl, pH 7.5, buffer and sonicated for 60 s. The resulting homogenate was centrifuged at 8,000 x g for 30 min at 4 °C, and the supernatant was recovered. The extracted proteins were reduced by adjusting the solution to 1 mM DTT and incubating for 2 h at 50 °C. An S-alkylation treatment was then done by adjusting the solution to 2.5 mM iodoacetamide and incubating for 1 h at 25 °C in the dark. After the S-carbamidomethylation, 4 times the volume of cold acetone (10 ml) was added to the protein solution and allowed to stand at 4 °C for 60 min in the dark to precipitate the proteins before centrifugation at 8,000 x g for 30 min at 4 °C. The resulting pellet was dried in a SpeedVac concentrator, redissolved in 25 µl of 100 mM pH 10.0 buffer consisting of glycine-NaOH and 8 M urea, and then diluted 8 times with 100 mM glycine-NaOH buffer (pH 10.0). The protein concentration was determined by the modified Bradford method (17). After protein quantification, protein concentrations of the untreated control and cytokine/LPS-treated sample were adjusted to be exactly equal in concentration (4 µg/µl) with 100 mM pH 10.0 buffer consisting of glycine-NaOH and 1 M urea and used for the experiments described below.

Protein Digestion by Lys-N
Validation Study—
Two equal aliquots of the above prepared untreated control cell protein samples (200 µg of protein/50 µl for each) were dried in a SpeedVac concentrator. In one tube, 25 µl of [16O]water was added and mixed with 4 µg of Lys-N in 25µl of [16O]water. In another tube, 25 µl of [18O]water was added and mixed with 4 µg of Lys-N in 25 µl of [18O]water. The final concentration of glycine-NaOH buffer (pH 10.0) and urea should thus be 100 mM and 1 M, respectively, in both the reaction tubes. The resulting two reaction tubes were then incubated at 25 °C for 18 h to digest the proteins. After incubation, the two digests were mixed in a 1:1 ratio and analyzed by liquid chromatography-tandem mass spectrometry.

Comparative Proteomic Study—
A 50-µl aliquot from each protein extract sample (treated and untreated, 200 µg of protein/50 µl for each) was dried in a SpeedVac concentrator. The protein pellet from the untreated control sample was redissolved in 25 µl of [16O]water and mixed with 4 µg of Lys-N in 25 µl of [16O]water. The protein pellet from the cytokine/LPS-treated sample was redissolved in 25 µl of [18O]water and mixed with 4 µg of Lys-N in 25 µl of [18O]water. The resulting two reaction mixtures were then incubated at 25 °C for 18 h to digest the proteins.

Cation Exchange Chromatography
The two digests (treated sample and untreated control) were then mixed in a 1:1 ratio and separated by strong cation exchange chromatography as follows. The cation exchange chromatography was performed using a strong cation exchange MicroBullet cartridge (12 µ, 300 Å, 2.0-mm inner diameter x 25 mm, Michrom BioResources, Inc., Auburn, CA) using a syringe pump (NP 70-2213 pump, Harvard Apparatus, Holliston, MA) as a solvent delivery system (18). The strong cation exchange column was first equilibrated with 1 ml of 5 mM ammonium formate adjusted to pH 3.2. An amount of 150 µg of protein of the mixed digest (37.5 µl) was diluted to 500 µl with 5 mM ammonium formate (adjusted to pH 3.2) and loaded onto the strong cation exchange column using a flow rate of 100 µl/min. The bound peptides from the strong cation exchange column were eluted stepwise with 200 µl each of the following eluents at a flow rate of 200 µl/min: 10, 40, 50, 80, 100, 150, and 500 mM ammonium formate (adjusted to pH 3.2). The unbound fraction and each of the stepwise eluents were collected and dried in a SpeedVac concentrator. Each dried fraction was then reconstituted in 20 µl of 0.1% TFA in [16O]water and analyzed by reversed-phase LC-MS/MS. Adjustment of ammonium formate solutions to pH 3.2 was done with formic acid.

LC-MS/MS Analysis
All LC-MS/MS analyses were done using an UltiMate nano-HPLC system (Dionex, San Francisco, CA) consisting of an isocratic pump, an autosampler, a gradient pump module, and a column switching module interfaced to a QStar quadrupole/time-of-flight mass spectrometer (Applied Biosystems-MDS Sciex, Foster City, CA) via a nano-electrospray ion source (Applied Biosystems-MDS Sciex) and a metal sprayer (New Objective Inc., Woburn, MA). Protein digests (5 µl) were injected into a reversed-phase C4 trapping column (300-µm inner diameter x 1 mm, Dionex) equilibrated with 0.1% formic acid, 2% acetonitrile (v/v) and washed for 5 min with the equilibration solvent at a flow rate of 10 µl/min using an isocratic pump that pumped the solvent through an autosampler. After the washing, the trapping column was switched in-line with the reversed-phase analytical column (0.075 x 50 mm, New Objective Inc.) packed in-house with Jupiter C18 media (10 µm, 300 Å, Phenomenex, Torrance, CA). A gradient pump module was used to produce a linear gradient of acetonitrile from 2 to 35% in aqueous 0.1% formic acid over a period of 100 min at a flow rate of 200 nl/min. After the gradient elution, the acetonitrile concentration was increased by a step change to 80% and maintained for 20 min at a flow rate of 200 nl/min. The column effluent was passed directly into the nanoelectrospray ion source attached to the metal sprayer on which 2,050 V of electrospray voltage was applied. The mass spectrometer was operated in a data-dependent MS to MS/MS switching mode with the three most intense ions in each MS scan subjected to MS/MS analysis. Survey MS spectra (from m/z 400 to 2,000) were acquired in the TOF analyzer with 1-s accumulation time. The three most intense ions in each survey TOF-MS analysis were sequentially selected in the first quadrupole mass analyzer and fragmented in the collision cell by collision-induced dissociation with nitrogen gas, and then the generated fragment ions were analyzed in the TOF analyzer using a 2-s accumulation time per precursor ion. The collision energy used for each precursor ion was dynamically selected based on its m/z value and charge state. Previously selected precursor ions were excluded for 60 s. AnalystQS software (version 1.0, Applied Biosystems-MDS Sciex) was used for instrument control, data acquisition, and data processing.

Protein Identification
Proteins were identified by comparing all of the experimental product ion spectra of the peptides to the Swiss-Prot database using the Mascot database search software (Matrix Science, London, UK). Only human proteins were searched. S-Carbamidomethylation of cysteine was set as a fixed modification. 18O labeling of the carboxyl terminus of the peptide and the oxidation of methionine (methionine sulfoxide) were set as variable modifications in the database search. Mass tolerances for protein identification on precursor and product ions were both set to 0.2 Da. Strict Lys-N specificity was applied while allowing for one missed cleavage. A minimum Mascot search score of 15 was used as the cutoff for a positive identification.

Calculation of Corrected 16O/18O-Peptide Ratios
Precursor peptide ions identified by the Mascot database search were manually extracted from the LC-MS/MS raw data on AnalystQS software, and the peak intensities of 16O- and 18O-labeled peptides were obtained from the extracted signal. The peak intensities for the 16O- and 18O-labeled peptides were corrected for 1) the effect of 5% H216O in the [18O]water and 2) the contribution of the M + 2 isotope of the 16O-labeled peptide to 18O-labeled peptide peak. A corrected 16O/18O peptide ratio was calculated as described previously (5).


    RESULTS
 TOP
 ABSTRACT
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Validation of Lys-N-based 18O Labeling Method—
Previously we have shown that the Lys-N-catalyzed 18O labeling method provides accurate quantification results using several model proteins (5). What remains to be done is validation of the applicability of the method for biological samples. This was done by taking equal amounts of reduced and S-carbamidomethylated proteins extracted from the control (untreated ARPE-19 cells) and then digesting in separate experiments using Lys-N in either H216O or in H218O. After the digestion, the two digests were mixed in a 1:1 ratio and analyzed directly by LC-MS/MS. As described under "Experimental Procedures," identities of the peptides were determined through database searching, and the corrected ratios of 16O- and 18O-labeled peptides were calculated.

Theoretically the 16O- and 18O-labeled peptide ratios of all the generated peptides should be 1:1. Corrected ratios of 16O- and 18O-labeled peptides for 121 Lys-N peptides arising from 40 different proteins are given in Fig. 1. For most of the peptides the corrected 16O/18O peptide ratios were within the 0.5–2.0 range compared with the theoretical ratio of 1. However, 21 peptides (17% of 121 peptides) gave ratios below 0.5 or above 2.0, implying false results for 17% of the peptides for biological samples analyzed by this method under the conditions specified.



View larger version (25K):
[in this window]
[in a new window]
 
FIG. 1. Distributions of the corrected 16O/18O ratios of 121 Lys-N peptides. Reduced and S-carbamidomethylated proteins from the cytokine/LPS-untreated human ARPE-19 cells were digested in H216O or H218O and mixed in a 1:1 ratio, and then 20 µg were analyzed by LC-MS/MS. The horizontal solid line represents the theoretical 16O/18O ratio. The dashed lines at 0.5 and 2.0 are the limits in which quantification can be accurately reported. Peptides that have corrected 16O/18O peptide ratios within 0.5–2.0 are denoted by {circ}, those below 0.5 or above 2.0 and with discrepancies explained in the text are denoted by {triangleup}, and those below 0.5 or above 2.0 and with discrepancies unexplained are denoted by x.

 
We further analyzed the peptide sequences of the 21 discrepant peptides as well as amino acid sequences before and after the cleavage sites of these peptides. The results are shown in Table I. The analysis revealed that 11 of the 21 discrepant peptides were products of cleavage on one or more of the following amino acid sequences: 1) -Lys-X0–3-Lys- (two lysine residues separated by no more than three other amino acids), 2) -Glu-Lys-, and 3) -Pro-Lys-. This strongly suggests that slow hydrolysis is occurring compared with other X-Lys bonds, resulting in variable degrees of cleavage between the two samples at these sites, explaining half of the discrepant results. Slower cleavage rates for -Glu-Lys- and -Pro-Lys- bonds were also suggested in our previous study of several model proteins (5). This finding is significant because it can reduce false results significantly by eliminating from consideration for quantification any peptides that were produced from these sequences, reducing the 17% false results to 8% (10 peptides of 121) in this experiment. We could not find any consensus sequences for the other 10 discrepant peptides.


View this table:
[in this window]
[in a new window]
 
TABLE I Amino acid sequences of discrepant peptides

 
It should be noted in Fig. 1 that 25% of peptides gave a corrected 16O/18O peptide ratio of between 0.5 and 0.75 or between 1.5 and 2.0 (1.5–2.0-fold change from the theoretical ratio), suggesting a threshold of ±2-fold change for deciding whether a protein concentration is changed in a comparative proteomic experiment. In addition, the distributions of the corrected 16O/18O peptide ratios were somewhat biased toward greater than 1.0 for most of the peptides (greater amount of 16O-lableled peptides than 18O-lableled peptides). This is probably due to the incomplete removal of [16O]water from the protein extract subjected to Lys-N digestion in H218O. Further work will need to be done to definitely identify the cause of this phenomenon to obtain even greater accuracy in quantification.

It is instructive to examine product ion spectra of Lys-N peptides produced by the low energy collision-induced dissociation used in this work. Product ion spectra of two representative Lys-N peptides are shown in Fig. 2. The first peptide is KNQLTSNPENTVFDA. This peptide shows a typical spectrum obtained for a Lys-N peptide. As can be seen in Fig. 2a, the predominant fragment ions observed in the product ion spectrum were b-type ions. This is in contrast to the product ion spectra of tryptic peptides in which y-type ions are generally more predominant than b-type ions (19). This may be attributed to the preferential localization of positive charges on {alpha}- and/or {epsilon}-amino group(s) of the amino-terminal lysine residue for Lys-N-generated peptides. The second peptide is KYNQLLRIEEELGS (Fig. 2b). This peptide has a basic amino acid residue (arginine) in the middle of the peptide. Such peptides are known to produce complex product ion spectra arising, at least in part, from internal rearrangements of the b-type ions (20). As can be seen in the product ion spectrum (Fig. 2b), predominant ions were still b-type with y-type ions containing the arginine residue also present. The spectra presented and the fact that 1,046 peptides from 584 proteins were identified in the comparative proteomic study (see below) confirm the effectiveness of the Mascot database search software in identifying proteins from Lys-N-generated peptides. This is seen even though the fragmentation patterns of Lys-N peptides are different from those of tryptic peptides and for peptides that have a basic amino acid residue in the middle of the sequence.



View larger version (50K):
[in this window]
[in a new window]
 
FIG. 2. Tandem mass spectra of Lys-N peptides. Tandem mass spectra of KNQLTSNPENTVFDA (molecular weight, 1,676.8; precursor ion, m/z 846.5) (a) and KYNQLLRIEEELGS (molecular weight, 1,690.9; precursor ion, m/z 846.5) (b) are shown. Peaks annotated as b and y correspond to singly charged fragments, and peaks labeled b2+ and y2+ correspond to doubly charged fragments.

 
Comparative Proteomic Study on Cytokine/LPS-treated ARPE-19 Cells—
Proteins from cytokine/LPS-treated and untreated (control) ARPE-19 cells were digested in H218O and H216O solvent, respectively, mixed in a 1:1 ratio, and then separated into eight fractions by strong cation exchange chromatography. The eight fractions were analyzed one-by-one by reversed-phase LC-MS/MS. The obtained LC/MS/MS data were subjected to a Mascot database search for peptide sequencing and subsequent protein identification. Peak intensities of each identified 16O- and 18O-labeled peptide were obtained and corrected as described under "Experimental Procedures."

These analyses resulted in the identification of 584 proteins in the cells, listed in Supplemental Table I along with peptide sequences identified. Relative abundances for most of these proteins were determined except for 22 proteins that were identified solely by a single carboxyl-terminal peptide because the carboxyl-terminal peptide of a protein does not incorporate 18O atom by this method. A total of 1,046 peptides were quantified through manual data analysis to determine the ratio of each peptide in the two samples. Note that any corrected 16O/18O peptide ratios greater than 10 or smaller than 0.1 were recorded as ratios >10 or <0.1 because this method may not be accurate for these large -fold changes (5). Proteins were identified from various cellular compartments. The highest number came from the cytoplasm (~19%) followed by 17% from the membrane, 13% from the nucleus, 7% from the mitochondrial, 2% from the endoplasmic reticulum, and 1% from lysosomes. Approximately 32% of proteins were from unknown locations. As expected, this method has the capability of identifying membrane proteins, which are generally difficult to identify by the commonly used 2D PAGE method. As far as we know this is the most comprehensive description of a proteome in RPE that has been reported.

The expression levels of 11 proteins were found to be greater than 2-fold in cytokine/LPS-treated cells compared with untreated control cells (16O/18O peptide ratio <0.5) (Table II). Among the 11 proteins, five proteins (indoleamine 2,3-dioxygenase (21), intercellular adhesion molecule-1 (22), interferon-induced guanylate-binding protein (23), plasminogen activator inhibitor-1 (24), and tryptophanyl-tRNA synthetase (25)) were previously known to be induced by cytokines, providing further evidence supporting the quantitative reliability of the technique. The other six proteins are not previously known to be induced by cytokines. Further work will need to be done to substantiate that these identified proteins are in fact induced by cytokines.


View this table:
[in this window]
[in a new window]
 
TABLE II Proteins expressed in greater amount in the cytokine/LPS-treated ARPE-19 cells

 
We also found 49 proteins whose expression levels appeared to be decreased by a factor of 2 or more in the cytokine/LPS-treated cells compared with those in the control untreated cells (16O/18O peptide ratio >2.0). A list of these proteins is provided in Supplemental Table II. Note that proteins that were identified exclusively by peptides that were the products of cleavage of one or more of the following amino acid sequences: 1) -Lys-X0–3-Lys-, 2) -Glu-Lys-, and 3) -Pro-Lys-, were not included in Table II and Supplemental Table II due to the variability considerations described previously even though the experimentally obtained corrected 16O/18O peptide ratios for these proteins are given in Supplemental Table I.


    DISCUSSION
 TOP
 ABSTRACT
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
The advantages of Lys-N-based 18O labeling method compared with trypsin-based methods are as follows: 1) incorporation of only a single 18O atom, 2) no enzyme-catalyzed 18O back-exchange, and 3) production of a less complex protein digest (5). In this study, a total of 1,046 peptides were sequenced and quantified, leading to the identification and quantification of 562 proteins (excluding 22 proteins that were identified solely by a single carboxyl-terminal peptide), comparing the relative abundances of proteins of the cytokine/LPS-treated and untreated (control) ARPE-19 cells. This is the most comprehensive description of the RPE proteome that has been reported. These results demonstrate the usefulness of Lys-N-based proteolytic 18O labeling method in proteomic studies.

Our validation study revealed that peptides generated by cleavages on one or more of the following amino acid sequences: 1) -Lys-X0–3-Lys-, 2) -Glu-Lys-, and 3) -Pro-Lys-, may not be accurately quantified due to presumed incomplete cleavage at these sites under the given digestion conditions. The recognition of amino acid sequences that have been shown to give inaccurate quantification results is significant because the inaccuracy of the technique can be reduced by excluding peptides generated from one or more of these sequences. The incomplete protein digestion for particular amino acid sequences is a drawback of this method. Efforts to achieve complete digestion of substrate proteins by Lys-N are in progress.

We must assume that our results contain false positive results (~8%) based on the validation experiment. One effective way to reduce false positive results would be to perform a reverse labeling experiment in which proteins from the control and experimental sample are digested in H218O and H216O, respectively, and compare the results with the results presented (control and experimental sample were digested in H216O and H218O, respectively). However, such an experiment would require an enormous amount of effort to complete unless software that can accelerate the data interpretation process becomes available as discussed below.

In the present study, quantification of each peptide was performed manually without the help of computational tools. It was an extremely time-consuming process. It took an experienced mass spectrometrist more than 3 months to complete the quantification of all 1,046 positively identified peptides (~4 h/day). The manual analysis included the following: 1) extraction of each 16O- and 18O-labeled peptide peak from the LC/MS/MS raw data based on Mascot database search results, 2) measurement of signal intensities of each 16O- and 18O-labeled peptide, and 3) calculation of corrected 16O- and 18O-labeled peptide ratio by incorporating the contribution of M + 2 isotope of the 16O-labeled peptide to the 18O-labeled peptide peak. Recently Halligan et al. (26) developed a stand alone computational tool that quantifies the mass spectra of 18O-labeled peptides from an ion trap instrument. Development of such software that can handle data produced by any type of commercial instruments will greatly facilitate the use of the proteolytic 18O labeling method in comparative proteomics.

The identified proteins are assumed to be relatively high abundance proteins. In this study, we separated peptides by strong cation exchange chromatography followed by reversed-phase chromatography. We observed many peptides that were not subjected to MS/MS analysis in the survey MS spectra because their signal intensities were not within the three most intense signal peaks. Therefore there was no sequence information for these peptides, indicating that more peptides could be analyzed with the development of better peptide separation techniques. This confirms the importance of achieving better peptide separation before mass spectrometric analysis to identify low abundance proteins.


    ACKNOWLEDGMENTS
 
We thank Ryan T. Carruth for technical assistance in LC/MS/MS analysis and Hemanarasimha K. Veluguleti for assistance in assembling information on proteins from the protein sequence databases. We also especially thank Dr. David J. Anderson (Cleveland State University, Cleveland, OH) for helpful discussions.


   FOOTNOTES
 
Received, May 23, 2005, and in revised form, June 27, 2005.

Published, MCP Papers in Press, July 5, 2005, DOI 10.1074/mcp.M500150-MCP200

1 The abbreviations used are: 2D, two-dimensional; LPS, lipopolysaccharide; Lys-N, peptidyl-Lys metalloendopeptidase; RPE, retinal pigment epithelium; DMEM, Dulbecco’s modified Eagle’s medium. Back

* This work was supported in part by NEI, National Institutes of Health Grant RO3 EY014020 (to M M.), Grant P20 RR016741 from the IDeA Network of Biomedical Research Excellence program of the National Center for Research Resources, and Grant P20RR017699 from the Center of Biomedical Research Excellence program of the National Center for Research Resources. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

S The on-line version of this article (available at http://www.mcponline.org) contains supplemental material. Back

To whom correspondence should be addressed: Dept. of Biochemistry and Molecular Biology, University of North Dakota School of Medicine and Health Sciences, 501 North Columbia Rd., Grand Forks, ND 58203. Tel.: 701-777-2760; Fax: 701-777-2382; E-mail: mmiyagi{at}medicine.nodak.edu


    REFERENCES
 TOP
 ABSTRACT
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Zhu, H., Bilgin, M., and Snyder, M. ( 2003) Proteomics Annu. Rev. Biochem. 72, 783 –812

  2. Yao, X., Freas, A., Ramirez, J., Demirev, P. A., and Fenselau, C. ( 2001) Proteolytic 18O labeling for comparative proteomics: model studies with two serotypes of adenovirus. Anal. Chem. 73, 2836 –2842[CrossRef][Medline]

  3. Gygi, S. P., Rist, B., Gerber, S. A., Turecek, F., Gelb, M. H., and Aebersold, R. ( 1999) Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat. Biotechnol. 17, 994 –999[CrossRef][Medline]

  4. Schnolzer, M., Jedrzejewski, P., and Lehmann, W. D. ( 1996) Protease-catalyzed incorporation of 18O into peptide fragments and its application for protein sequencing by electrospray and matrix-assisted laser desorption/ionization mass spectrometry. Electrophoresis 17, 945 –953[CrossRef][Medline]

  5. Rao, K. C. S., Carruth, R. T., and Miyagi, M. ( 2005) Proteolytic 18O labeling by peptidyl-Lys metalloendopeptidase for comparative proteomics. J. Proteome Res. 4, 507 –514[CrossRef][Medline]

  6. Nonaka, T., Dohmae, N., Hashimoto, Y., and Takio, K. ( 1997) Amino acid sequences of metalloendopeptidases specific for acyl-lysine bonds from Grifola frondosa and Pleurotus ostreatus fruiting bodies. J. Biol. Chem. 272, 30032 –30039[Abstract/Free Full Text]

  7. Dunn, K. C., Aotaki-Keen, A. E., Putkey, F. R., and Hjelmeland, L. M. ( 1996) ARPE-19, a human retinal pigment epithelial cell line with differentiated properties. Exp. Eye Res. 62, 155 –169[CrossRef][Medline]

  8. Holtkamp, G. M., Kijlstra, A., Peek, R., and de Vos, A. F. ( 2001) Retinal pigment epithelium-immune system interactions: cytokine production and cytokine-induced changes. Prog. Retin. Eye Res. 20, 29 –48[CrossRef][Medline]

  9. Bevitt, D. J., Mohamed, J., Catterall, J. B., Li, Z., Arris, C. E., Hiscott, P., Sheridan, C., Langton, K. P., Barker, M. D., Clarke, M. P., and McKie, N. ( 2003) Expression of ADAMTS metalloproteinases in the retinal pigment epithelium derived cell line ARPE-19: transcriptional regulation by TNF{alpha}. Biochim. Biophys. Acta 1626, 83 –91[Medline]

  10. Narayan, S., Prasanna, G., Krishnamoorthy, R. R., Zhang, X., and Yorio, T. ( 2003) Endothelin-1 synthesis and secretion in human retinal pigment epithelial cells (ARPE-19): differential regulation by cholinergics and TNF-{alpha}. Investig. Ophthalmol. Vis. Sci. 44, 4885 –4894[Abstract/Free Full Text]

  11. Udono, T., Takahashi, K., Nakayama, M., Murakami, O., Durlu, Y. K., Tamai, M., and Shibahara, S. ( 2000) Adrenomedullin in cultured human retinal pigment epithelial cells. Investig. Ophthalmol. Vis. Sci. 41, 1962 –1970[Abstract/Free Full Text]

  12. West, K. A., Yan, L., Miyagi, M., Crabb, J. S., Marmorstein, A. D., Marmorstein, L., and Crabb, J. W. ( 2001) Proteome survey of proliferating and differentiating rat RPE-J cells. Exp. Eye Res. 73, 479 –491[CrossRef][Medline]

  13. West, K. A., Yan, L., Shadrach, K., Sun, J., Hasan, A., Miyagi, M., Crabb, J. S., Hollyfield, J. G., Marmorstein, A. D., and Crabb, J. W. ( 2003) Protein database, human retinal pigment epithelium. Mol. Cell. Proteomics 2, 37 –49[Abstract/Free Full Text]

  14. Alge, C. S., Suppmann, S., Priglinger, S. G., Neubauer, A. S., May, C. A., Hauck, S., Welge-Lussen, U., Ueffing, M., and Kampik, A. ( 2003) Comparative proteome analysis of native differentiated and cultured dedifferentiated human RPE cells. Investig. Ophthalmol. Vis. Sci. 44, 3629 –3641[Abstract/Free Full Text]

  15. Bonilha, V. L., Bhattacharya, S. K., West, K. A., Sun, J., Crabb, J. W., Rayborn, M. E., and Hollyfield, J. G. ( 2004) Proteomic characterization of isolated retinal pigment epithelium microvilli. Mol. Cell Proteomics 3, 1119 –1127[Abstract/Free Full Text]

  16. Khanobdee, K., Kolberg, J. B., and Dunlevy, J. R. ( 2004) Nuclear and plasma membrane localization of SH3BP4 in retinal pigment epithelial cells. Mol. Vis. 10, 933 –942[Medline]

  17. Ramagli, L. S. ( 1999) Quantifying protein in 2-D PAGE solubilization buffers. Methods Mol. Biol. 112, 99 –103[Medline]

  18. Fujii, K., Nakano, T., Kawamura, T., Usui, F., Bando, Y., Wang, R., and Nishimura, T. ( 2004) Multidimensional protein profiling technology and its application to human plasma proteome. J. Proteome Res. 3, 712 –718[CrossRef][Medline]

  19. Tang, X. J., and Boyd, R. K. ( 1992) An investigation of fragmentation mechanisms of doubly protonated tryptic peptides. Rapid Commun. Mass Spectrom. 6, 651 –657[CrossRef][Medline]

  20. Tang, X. J., Thibault, P., and Boyd, R. K. ( 1993) Fragmentation reactions of multiply-protonated peptides and implications for sequencing by tandem mass spectrometry with low-energy collision-induced dissociation. Anal. Chem. 65, 2824 –2834[CrossRef][Medline]

  21. Babcock, T. A., and Carlin, J. M. ( 2000) Transcriptional activation of indoleamine dioxygenase by interleukin 1 and tumor necrosis factor {alpha} in interferon-treated epithelial cells. Cytokine 12, 588 –594[CrossRef][Medline]

  22. Platts, K. E., Benson, M. T., Rennie, I. G., Sharrard, R. M., and Rees, R. C. ( 1995) Cytokine modulation of adhesion molecule expression on human retinal pigment epithelial cells. Investig. Ophthalmol. Vis. Sci. 36, 2262 –2269[Abstract]

  23. Anderson, S. L., Carton, J. M., Lou, J., Xing, L., and Rubin, B. Y. ( 1999) Interferon-induced guanylate binding protein-1 (GBP-1) mediates an antiviral effect against vesicular stomatitis virus and encephalomyocarditis virus. Virology 256, 8 –14[CrossRef][Medline]

  24. Chowers, I., Kim, Y., Farkas, R. H., Gunatilaka, T. L., Hackam, A. S., Campochiaro, P. A., Finnemann, S. C., and Zack, D. J. ( 2004) Changes in retinal pigment epithelial gene expression induced by rod outer segment uptake. Investig. Ophthalmol. Vis. Sci. 45, 2098 –2106[Abstract/Free Full Text]

  25. Bange, F. C., Flohr, T., Buwitt, U., and Bottger, E. C. ( 1992) An interferon-induced protein with release factor activity is a tryptophanyl-tRNA synthetase. FEBS Lett. 300, 162 –166[CrossRef][Medline]

  26. Halligan, B. D., Slyper, R. Y., Twigger, S. N., Hicks, W., Olivier, M., and Greene, A. S. ( 2005) ZoomQuant: an application for the quantitation of stable isotope labeled peptides. J. Am. Soc. Mass Spectrom. 16, 302 –306[CrossRef][Medline]





This Article
Abstract
Full Text (PDF)
Supplemental Data
All Versions of this Article:
M500150-MCP200v1
4/10/1550    most recent
Submit a response
Purchase Article
View Shopping Cart
Alert me when this article is cited
Alert me when eLetters are posted
Alert me if a correction is posted
Citation Map
Services
Email this article to a friend
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Glossary
Copyright Permissions
Google Scholar
Articles by Rao, K. C. S.
Articles by Miyagi, M.
Articles citing this Article
PubMed
PubMed Citation
Articles by Rao, K. C. S.
Articles by Miyagi, M.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Journal of Lipid Research   Biochemistry and Molecular Biology Education